InMed Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
IMLFF InMed Pharmaceuticals Inc
PNW Pinnacle West Capital Corp
AAPL Apple Inc
NAII Natural Alternatives International Inc
SJMiv.P Invesco BulletShares 2022 Hi Yld Corp Bd ETF
INTC Intel Corp
VAL Valaris PLC
GE General Electric Co
XOM Exxon Mobil Corp
MSFT Microsoft Corp

Health Care : Biotechnology | Small Cap Growth
Based in CanadaCompany profile

InMed Pharmaceuticals Inc. is a pre-clinical-stage biopharmaceutical company. The Company specializes in the research and development of cannabinoid-based therapies combined with drug delivery systems. The Company operates through the segment of research and development of pharmaceutical cannabis based-therapies. The Company is working on two products, which include INM-750, for the treatment of Epidermolysis Bullosa (EB), and INM-085, for the treatment of Glaucoma. The INM-750 is a therapy developed for EB designed specifically to modulate disease activity and to alleviate symptoms. The INM-085 is designed as a dual-action cannabinoid ocular therapy. INM-085 is designed as a topical formulation to be administered directly to the eye. It is working on the development of several cannabinoid-based treatments for multiple diseases, including ocular, dermatology, cancer, inflammation, pain and arthritis disease areas. Its subsidiary is Biogen Sciences Inc. (BSI).

Closing Price
Day's Change
0.0234 (12.58%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Three momentum stocks to watch after company earnings reports

12:50 pm ET November 22, 2019 (MarketWatch)

By Harry Boxer

In focus: Clovis Oncology, Luckin Coffee and Luna Innovations

Here are three stocks with continued technical momentum in the days and weeks after strong earnings releases.

Clovis Oncology Inc.(CLVS) jumped 75 cents to $7.76 on 8.1 million shares traded Thursday. The move continued the stock's run-up following the biotech company's better-than-expected earnings release two weeks ago. The stock closed right above lateral resistance, and next target is the rising channel top near $9-$9.25.

Luckin Coffee Inc.(LK) popped $1.65 to $27.95 on 14.4 million shares traded Thursday, more than three times its average volume. Shares in the China-based company have been running since its Nov. 13 quarterly financial release that topped analysts' estimates. The stock in recent days pulled back from its high, before Thursday's move. A break back above Tuesday's intraday high of $28.85 could get this to $30-$32 next.

Luna Innovations Inc.(LUNA) climbed 20 cents to $7.13 on 636,300 shares traded Thursday. The move, on nearly double the average volume, came on no news from the fiber optic-based technology company, though the stock has been climbing (now up about 20%) since the company's Nov. 5 earnings release. The stock made a new all-time high at $7.40 intraday Thursday, with the rising channel top pointing to above $8.

See Harry's video-chart analysis on these stocks (

The writer has no holdings in any securities mentioned.

Harry Boxer is founder of (, a live trading room featuring his stock picks, technical market analysis and live chart presentations.

-Harry Boxer; 415-439-6400;

(END) Dow Jones Newswires

November 22, 2019 12:50 ET (17:50 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.